SCHEMBL6987593

SCHEMBL6987593

C(CC1CC1)Oc1nsnc1OC1C2CCC1NC2

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980912 1.00 CHRM1 (0.39) CHRM1
SCHEMBL6985817 0.87 CHRM1 (0.35) CHRM1
SCHEMBL6980919 0.86 CHRM1 (0.48) CHRM1
SCHEMBL6988257 0.84 CHRM1 (0.59) CHRM1
SCHEMBL6981312 0.83 CHRM1 (0.43) CHRM1
SCHEMBL6989733 0.82 CHRM1 (0.33) CHRM1
SCHEMBL6989372 0.80 CHRM1 (0.38) CHRM1
SCHEMBL6987451 0.79 CHRM1 (0.39) CHRM1
SCHEMBL6981474 0.79 CHRM1 (0.36) CHRM1
Hydrochloric Acid SCHEMBL6985417 0.78 CHRM1 (0.35) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189902-B1 7-OXO-2-AZABICYCLO[2.2.1]HEPTANES AS SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST LILLY CO ELI (US) 2003-08-27 EP claimed
US-6559171-B1 Muscarinic receptor modulators 7-oxo-2-azabicyclo(2.2.1)heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, ELI LILLY AND COMPANY 2003-05-06 US claimed